Isracann BioSciences Inc.
Isracann Biosciences, Inc. is an Israeli-based cannabis company. It focuses on producing low-cost cannabis. The company was founded on January 21, 2010 and is headquartered in Vancouver, Canada.
Top 10 Reasons Why I Believe ISCNF is Poised to Succeed in the World’s Largest Cannabis Market
- Global cannabis use and acceptance is growing within all consumer segments, with an estimated global market size of $146.6B by 2025.[69]
- Europe is the world’s largest, untapped market of 740 million people.[70]
- EU medical market is estimated to be worth $64B USD by 2028.[71]
- Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer.
- It will offer a one-stop medicinal cannabis solution to all European countries where it is legal.
- Israel boasts the best growing climate for cannabis in the world… allowing Isracann to achieve low-cost production (est. $0.40/gram).[72]
- Israel boasts a history of innovation in technology and premium agriculture, and Isracann (ISCNF) plans to leverage that to dominate both the domestic and European markets.
- In a major milestone initiative, Israel approved legislative framework for export of medical cannabisin January 2019.[73]
- Initial entry point is Germany, a medical market with extremely large potential. In 2018 German health care covered over $75 million of cannabis products.[74]
- Besides me, very few analysts are following this fast expanding, under-the-radar cannabis opportunity in the European market.
Isracann BioSciences Inc.(ISCNF) On 
Isracann BioSciences Inc.(ISCNF) In the Media
IsraCann Biosciences
- Isracann Biosciences Provides Bi-Weekly Default Status Report
- Isracann Biosciences Announces Delay in Filing Annual Financial Statements
- Isracann Bioscience Facilitated Genetics Arrive in Israel
- Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel
- Praesidio signs distribution agreement with Pure Integrative Pharmacy
- Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board
- Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement
- Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada
- Isracann Biosciences Renews Leadership to Meet Changing Demands
- Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers
ADVERTISEMENT DISCLAIMER
THIS PUBLICATION IS AN ISSUER-PAID ADVERTISEMENT.
This paid advertisement includes a stock profile of Isracann BioSciences (OTCQB: ISCNF) (“ISCNF”). To enhance public awareness of ISCNF and its securities, the issuer has provided Promethean Marketing, Inc. (“Promethean”) with a total budget of approximately nine hundred and sixty five thousand ($965,000.00) USD to cover the costs associated with this advertisement for a period beginning 1 December 2020 and currently set to end 31 March 2022. In connection with this effort, Promethean has paid the author of this advertisement, DiGeorgia fifteen thousand nine hundred and fifty ($15,950.00) USD in cash out of the total budget. The website hosting this advertisement, Daily Trade Report, is owned by Summit Publishing Group, Inc. (“Summit”), an affiliate of Promethean. Neither Summit nor Daily Trade Report have been paid to host this advertisement. As a result of this advertisement, Daily Trade Report may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. Promethean will retain any excess sums after all expenses are paid. James DiGeorgia is solely responsible for the contents of this advertisement. As of the date this advertisement is posted to the Daily Trade Report website, some or all of Promethean, Daily Trade Report, Summit, or James DiGeorgia, and any of their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) may hold the securities of ISCNF’s and may sell those shares during the course of this advertising campaign. This advertisement may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of ISCNF, increased trading volume, and possibly an increased share price of ISCNF’s securities, which may or may not be temporary and decrease once the advertising campaign has ended.
To more fully understand the Daily Trade Report website or service, please review its full Disclaimer and Disclosure Policy located here.
This paid advertisement includes a stock profile of Isracann BioSciences (OTCQB: ISCNF) (“ISCNF”). To enhance public awareness of ISCNF and its securities, the issuer has provided Promethean Marketing, Inc. (“Promethean”) with a total budget of approximately nine hundred and sixty five thousand ($965,000.00) USD to cover the costs associated with this advertisement for a period beginning 1 December 2020 and currently set to end 31 March 2022. In connection with this effort, Promethean has paid the author of this advertisement, DiGeorgia fifteen thousand nine hundred and fifty ($15,950.00) USD in cash out of the total budget. The website hosting this advertisement, Daily Trade Report, is owned by Summit Publishing Group, Inc. (“Summit”), an affiliate of Promethean. Neither Summit nor Daily Trade Report have been paid to host this advertisement. As a result of this advertisement, Daily Trade Report may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. Promethean will retain any excess sums after all expenses are paid. James DiGeorgia is solely responsible for the contents of this advertisement. As of the date this advertisement is posted to the Daily Trade Report website, some or all of Promethean, Daily Trade Report, Summit, or James DiGeorgia, and any of their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) may hold the securities of ISCNF’s and may sell those shares during the course of this advertising campaign. This advertisement may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of ISCNF, increased trading volume, and possibly an increased share price of ISCNF’s securities, which may or may not be temporary and decrease once the advertising campaign has ended.
To more fully understand the Daily Trade Report website or service, please review its full Disclaimer and Disclosure Policy located here.
* See our Important Notice and Disclaimer above for a detailed discussion on compensation, risks, atypical results, and more.
[69] https://isracann.com/wp-content/uploads/2018/11/Isracann-Presentation.pdf
[70] https://isracann.com/wp-content/uploads/2018/11/Isracann-Presentation.pdf
[72] https://isracann.com/wp-content/uploads/2018/11/Isracann-Presentation.pdf
